EGFR gene amplification and structural genetic alterations have been reported in several types of adenocarcinoma, including non-small-cell lung cancer, glioblastoma, pancreatic cancer, and squamous cell carcinoma of the head and neck. Here, EGFR is linked to squamous cell carcinoma.